These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

646 related items for PubMed ID: 16730951

  • 1. Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine.
    Byerly MJ, Nakonezny PA, Bettcher BM, Carmody T, Fisher R, Rush AJ.
    Schizophr Res; 2006 Sep; 86(1-3):244-50. PubMed ID: 16730951
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder.
    Byerly MJ, Nakonezny PA, Fisher R, Magouirk B, Rush AJ.
    Schizophr Res; 2006 Jan 31; 81(2-3):311-6. PubMed ID: 16298106
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M, Erol A, el Mahfoud Kessaci M, Shaheen MO, Sunbol MM, Boland J, Hodge A, O'Halloran RA, Bitter I, IC-SOHO Study Group.
    J Clin Psychiatry; 2004 Mar 31; 65(3):312-21. PubMed ID: 15096069
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.
    Suzuki T, Uchida H, Watanabe K, Nomura K, Takeuchi H, Tomita M, Tsunoda K, Nio S, Den R, Manki H, Tanabe A, Yagi G, Kashima H.
    Psychopharmacology (Berl); 2007 Dec 31; 195(2):285-95. PubMed ID: 17701027
    [Abstract] [Full Text] [Related]

  • 11. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
    Dossenbach M, Pecenak J, Szulc A, Irimia V, Anders M, Logozar-Perkovic D, Peciukaitiene D, Kotler M, Smulevich AB, West TM, Lowry AJ, Treuer T.
    J Clin Psychiatry; 2008 Dec 31; 69(12):1901-15. PubMed ID: 19012820
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.
    Dossenbach M, Dyachkova Y, Pirildar S, Anders M, Khalil A, Araszkiewicz A, Shakhnovich T, Akram A, Pecenak J, McBride M, Treuer T.
    Eur Psychiatry; 2006 Jun 31; 21(4):251-8. PubMed ID: 16530390
    [Abstract] [Full Text] [Related]

  • 14. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
    Castro-Fornieles J, Parellada M, Soutullo CA, Baeza I, Gonzalez-Pinto A, Graell M, Paya B, Moreno D, de la Serna E, Arango C.
    J Child Adolesc Psychopharmacol; 2008 Aug 31; 18(4):327-36. PubMed ID: 18759642
    [Abstract] [Full Text] [Related]

  • 15. Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone.
    Westheide J, Cvetanovska G, Albrecht C, Bliesener N, Cooper-Mahkorn D, Creutz C, Hornung WP, Klingmüller D, Lemke MR, Maier W, Schubert M, Sträter B, Kühn KU.
    J Sex Med; 2008 Dec 31; 5(12):2816-26. PubMed ID: 18466271
    [Abstract] [Full Text] [Related]

  • 16. Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trial.
    Lublin H, Haug HJ, Koponen H, Sigmundsson T, Kolb SA.
    World J Biol Psychiatry; 2009 Dec 31; 10(4 Pt 3):710-8. PubMed ID: 18803070
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
    Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Capuano GA, Rosenheck RA, Keefe RS, Miller AL, Belz I, Hsiao JK, CATIE Investigators.
    Am J Psychiatry; 2007 Mar 31; 164(3):415-27. PubMed ID: 17329466
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings.
    Mladsi DM, Grogg AL, Irish WD, Lopez RB, Degen K, Swann A, Nimsch CT.
    Curr Med Res Opin; 2004 Dec 31; 20(12):1883-93. PubMed ID: 15701206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.